Title: Econometica Milano
1Econometica Milano
- Global Justice and Health
- Intellectual Property Rights versus
- Access to Essential Medicines
- Thomas Pogge
- Professor of Political Science, Columbia
University - Centre for Applied Philosophy and Public Ethics,
Australian National University - Centre for the Study of Mind in Nature,
University of Oslo
2Our Shared Commitment
- Everyone has the right to a standard of living
adequate for the health and well-being of himself
and of his family, including food, clothing,
housing and medical care and necessary social
services, and the right to security in the event
of unemployment, sickness, disability, widowhood,
old age or other lack of livelihood in
circumstances beyond his control Article
25(1). - Universal Declaration of Human Rights
3Human Cost of Poverty Today
- Among 6450 million human beings (2004), about
- 830 million are undernourished (UNDP 2006, p.
174), - 2000 million lack access to essential drugs
(www.fic.nih.gov/about/summary.html), - 1100 million lack access to safe drinking water
(UNDP 2006, p. 33), - 1000 million lack adequate shelter (UNDP 1998, p.
49), - 2000 million have no electricity (UNDP 1998, p.
49), - 2600 million lack adequate sanitation (UNDP 2006,
p. 33), - 799 million adults are illiterate
(www.uis.unesco.org), - 211 million children (aged 5 to 14) do wage
work outside their family 8.4 million
of them in the unconditionally worst forms of
child labor, which involve slavery, forced or
bonded labor, forced recruitment for use in armed
conflict, forced prostitution or pornography, or
the production or trafficking of illegal drugs
(ILO A Future Without Child Labour, 2002, pp. 9,
11, 17-18). -
4One Third of all Human Deaths
- some 18 million per year or 50 000 daily are
due to poverty-related causes, cheaply
preventable through food, safe drinking water,
rehydration packs, vaccines or other medicines.
In thousands - diarrhea (1798), malnutrition (485),
- perinatal (2462) and maternal conditions (510),
- childhood diseases (1124 mainly measles),
- tuberculosis (1566), meningitis (173), hepatitis
(157), - malaria (1272), tropical diseases (129),
- respiratory infections (3963 mainly
pneumonia), - HIV/AIDS (2777), sexually transmitted diseases
(180) - (World Health Organization World Health
Report 2004, 120-5).
5Distribution of Deprivations
- Nearly all the deprived are persons of color.
- Children under age five account for 10.6 million
or 59 of avoidable deaths each year from hunger
and diseases (UNICEF The State of the Worlds
Children 2005). - Women and girls are substantially overrepresented
among the deprived (UNDP Human Development
Report 2003, pp. 310-330 UNIFEM UNRISD 2005
Social Watch Unkept Promises, 2005).
6Death Toll of Century's Atrocitieshttp//users.er
ols.com/mwhite28/war-1900.htm
7Millions of Deaths
8Income Poverty Relative to the World Banks
1/day and 2/day Poverty Lines
1/day (1.075/day PPP 1993) Amounts Per Year 2/day (2.15/day PPP 1993)
Poverty Line Poverty Gap Consumption Poverty Line Poverty Gap Consumption
393 PPP 1993 or today ca. 560 in USA 28.4 percent 112PPP1993 or today ca. 159 in USA 71.6 percent 281PPP1993 or today ca. 401 in USA In US PPP, per Person 786 PPP 1993 or today ca. 1120 in USA 42 percent 330PPP1993 or today ca. 470 in USA 58 percent 456PPP1993 or today ca. 650 in USA
70 to 280, depending on purchasing power of poor countrys currency 20 to 80, depending on purchasing power of poor countrys currency typically ca. 40 50 to 200, depending on purchasing power of poor countrys currency typically ca. 100 At market exchange rates, per Person 140 to 560, depending on purchasing power of poor countrys currency 60 to 240, depending on purchasing power of poor countrys currency typically ca. 120 80 to 320, depending on purchasing power of poor countrys currency typically ca. 160
ca. 1089 million extremely poor people (17 of humankind) ca. 44billion (versus 35142 billion social product of the rich countries containing 16 of humankind) ca. 109 billion (ca. 0.25 percent of the 45,000 billion global product) Aggregates (1 billion 1000 million) ca. 2735 million very poor people (43 of humankind) ca. 330 billion (versus 35142 billion social product of the rich countries containing 16 of humankind) ca. 440 billion (ca. 1 percent of the 45,000 billion global product)
9(No Transcript)
10Shares of World PopulationIncome Poorest
Households versus Richest Countries
11Shares of Global IncomeIncome Poorest
Households versus Richest Countries
Calculated in terms of market exchange rates so
as to reflect the avoidability of poverty.
Rich-Poor Ratio over 2001. Decile Inequality
Ratio 3201 (Milanovic 2005, pp. 111-12).
12Reported Changes in Population Below
1/DayChina and the Rest of the World (Chen
and Ravallion 2004)
13Reported Changes inPopulation Below
2/DayChina and the Rest of the World(Chen and
Ravallion 2004)
14(No Transcript)
15Shares of Global WealthPoorest versus Richest
Households
Calculated in terms of market exchange rates so
as to reflect the avoidability of poverty. Decile
Ineqty 28371. Quintile Ineqty 851. Year 2000,
125 trillion total. (James B Davies et al.
WIDER 2006)
16Defenses of the Existing Global Institutional
Order
- Causally inert (explanatory nationalism)
- (Nearly) best of all possible designs with
respect to human-rights fulfillment
17Defenses Defeated
- The Negative Case
- The fallacious argument from differential
trajectories
18 Global Institutional Order National Institutional Schemes of the Various Developing Countries
Poor and Vulnerable Citizens in the Developing Countries
19The Positive Case (3 Ps)
- Protectionism against the poor
- Pharmaceuticals at monopoly prices
- Privileges Borrowing, Resources, Treaties, Arms
20- Global Institutional Order
4 Privileges
Governments of the More Powerful (G-7) Countries National Institutional Schemes of the Various Developing Countries
Citizens of the More Powerful (G-7) Countries Poor and Vulnerable Citizens in the Developing Countries
Protectionism Pharmaceuticals
21Rules Governing Medical Research
- Under the TRIPs agreement, inventors of new drugs
can get a 20-year global monopoly. This regime
prices most new drugs beyond the reach of the
global poor. It also skews medical research
toward the affluent Diseases accounting for 90
of the global disease burden receive only 10 of
all medical research worldwide. Pneumonia,
diarrhea, tuberculosis and malaria, which account
for over 20 of the global disease burden,
receive less than 1 of all public and private
funds devoted to health research. Of the 1556 new
drugs approved between 1975 and 2004, only 18
were for tropical diseases and 3 for TB.
22Rules Governing Medical Research 2
- One obvious alternative is a regime under which
inventor firms can choose to be rewarded in
proportion to the impact of their invention on
the global disease burden. - This solution would end the morally untenable
situation of the drug companies, which must now,
to recover their costs, price life-saving
medications out of the reach of vast numbers of
poor patients. The solution would align the
interests of inventor firms and the generic drug
producers. The former would want their inventions
to be widely copied, mass-produced, and sold as
cheaply as possible, because this would magnify
the health impact of their inventions. If new
drugs were sold at the competitive price, near
the marginal cost of production, many poor
patients would gain access to drugs they now
cannot afford. And affluent patients would gain
as well, by paying substantially less for drugs
and medical insurance. - This solution would also greatly expand research
into diseases that now attract very little
research dengue fever, hepatitis, meningitis,
leprosy, trypanosomiasis (sleeping sickness and
Chagas disease), river blindness, leishmaniasis,
Buruli ulcer, lymphatic filariasis,
schistosomiasis (bilharzia), malaria,
tuberculosis, and many more. - In time, this one rule change alone would
easily halve the number of annual poverty deaths.
23The Consent Objection
- Governments of poor countries often
- - lack expertise
- - lack bargaining power
- - lack democratic legitimacy
- Most of those suffering are children
- Human rights understood as inalienable
24Injustice of an Institutional Order
- An institutional order is unjust if all four are
true - The institutional order is causally associated
with a massive human-rights deficit. - This causal association is foreseeable.
- This causal association is reasonably avoidable
through some alternative design of this
institutional order. - This avoidability is foreseeable (we can know
that the alternative institutional design would
do much better in giving participants secure
access to the objects of their human rights).
25Human Rights as Moral Claims on (Global)
Institutional Arrangements
- Everyone is entitled to a social and
international order in which the rights and
freedoms set forth in this Declaration can be
fully realized (Article 28) - Universal Declaration of Human Rights
26Individual Moral Claim
- A human right to X gives you a moral claim
against all others ? and them a correlative
negative duty ? that they not harm you by
cooperating, without compensating reform and
protection efforts, in imposing upon you an
institutional order under which you lack secure
access to X as part of a foreseeable and
foreseeably avoidable human rights deficit.
27Moral Responsibility
- When an institutional order is unjust (by
foreseeably producing massive and foreseeably
avoidable human-rights deficits), then those who
without compensating reform and protection
efforts are actively cooperating in designing
or imposing this order are harming (violating the
human rights of, violating a human-rights-correlat
ive negative duty toward) those who suffer the
avoidable human-rights deficits.
28Human Rights andCorrelative Duties
29Prospect for Reform
- Governments and corporations are under
continuous counter-moral pressures not merely
from ordinary profit motives, but also from their
competitive or adversarial situation and from
fairness considerations Each party may
reasonably judge that it cannot afford to forgo
wrongdoing or to act well, because such
unilateral self-restraint would place it at an
unfair competitive disadvantage vis-à-vis its
less scrupulous competitors.
30How Much